Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Oct 25, 2017Company Also Celebrates 50 Years of Cannula Production in ColumbusBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to break ground on a $60...
-
Sep 28, 2017
Mississauga, Ontario and Hamilton, Ontario - September 28, 2017 – BD (Becton, Dickinson and Company), a leading global medical technology company and the Canadian Society for Medical Laboratory...
-
Sep 26, 2017Fully-automated BD Phoenix(TM) CPO detect test helps detect dangerous pathogens
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch(1) of the first automated phenotypic test to detect and classify...
-
Sep 20, 2017New Molecular Assays Will be for Use on the BD MAX(TM) System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Euroclone (Euroclone Diagnostica Srl) today announced a development and global distribution...
Sep 19, 2017BD Ultra-Fine(TM) Micro 6mm Pen Needles Now AvailableBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the introduction of the BD Ultra-Fine(TM) micro pen needle 6mm x 32G for use with...
Sep 12, 2017BD Rhapsody(TM) single cell analysis system launches for gene expression profiling, plans to expand for protein analysisBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single cell analysis with the ability to...
-
Aug 28, 2017
SAN DIEGO, Aug. 28, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, Direct Relief and the National Association of Community Health Centers...
-
Aug 14, 2017
FRANKLIN LAKES, N.J., August 14, 2017 – BD (Becton, Dickinson and Company), a leading global medical technology company, has obtained 510(k) clearance from the U.S. Food and Drug Administration...
-
Aug 3, 2017
Click on the links below to view results for 2017 Third Fiscal Quarter: View Document Online PDF File of BD 2017 Third Fiscal Quarter Results About BD BD is one of the largest global medical...
Jul 19, 2017BD FACSLyric(TM) Flow Cytometer System with BD Multitest(TM) Assays Offers Reliability and ConsistencyBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...